Literature DB >> 2427548

Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity.

E A Johns, R Turner, E H Cooper, I C Maclennan.   

Abstract

Measurements of the isoelectric point (pI), sialic acid content, and polymerisation were made of 43 light chains isolated from the urine of patients with myelomatosis excreting large amounts of light chains. The pIs ranged from 3.5-9.5, and 23 were greater than 7.0. Sialylation was detected in 62% of light chains, and 69% showed microheterogeneity of charge. There was no clear association between the pI, sialylation, or polymerisation and the presence of renal failure, as assessed by serum creatinine concentrations. Light chains with pI spectrotype in the basic range, however, were found to produce more proximal tubular dysfunction than acidic light chains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427548      PMCID: PMC500103          DOI: 10.1136/jcp.39.8.833

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

Review 2.  Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

Authors:  T Maack; V Johnson; S T Kau; J Figueiredo; D Sigulem
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Detection of Bence-Jones protein by isoelectric focussing of unconcentrated urine followed by nitrocellulose blotting and immunoperoxidase staining.

Authors:  A G Norden; L M Fulcher; F V Flynn
Journal:  Clin Chim Acta       Date:  1985-12-31       Impact factor: 3.786

5.  The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma.

Authors:  R A Coward; I W Delamore; N P Mallick; E L Robinson
Journal:  Clin Sci (Lond)       Date:  1984-02       Impact factor: 6.124

6.  The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.

Authors:  T A Waldmann; W Strober; R P Mogielnicki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

7.  Myeloma kidney cast nephropathy in a rat model of multiple myeloma.

Authors:  P Smolens; M Venkatachalam; J H Stein
Journal:  Kidney Int       Date:  1983-08       Impact factor: 10.612

8.  The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments.

Authors:  R D Wochner; W Strober; T A Waldmann
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

9.  Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point.

Authors:  D H Clyne; A J Pesce; R E Thompson
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

10.  Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial.

Authors:  E H Cooper; M A Forbes; R A Crockson; I C MacLennan
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

  10 in total
  4 in total

1.  Renal impairment in myeloma: negative association with isoelectric point of excreted Bence-Jones protein.

Authors:  A G Norden; F V Flynn; L M Fulcher; J D Richards
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

2.  Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo.

Authors:  P W Sanders; G A Herrera; A Chen; B B Booker; J H Galla
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

3.  Electrophoretic study of the physico-chemical characteristics of Bence-Jones proteinuria and its association with kidney damage.

Authors:  M C Diemert; L Musset; O Gaillard; S Escolano; A Baumelou; F Rousselet; J Galli
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

4.  Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney).

Authors:  Stephanie Stringer; Kolitha Basnayake; Colin Hutchison; Paul Cockwell
Journal:  Bone Marrow Res       Date:  2011-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.